BioSpace News Archive

HepaTx, a preclinical-stage biotechnology company developing cell therapies for liver disease, is proud to announce the addition of Dr. Avnesh Thakor

P360, a leading developer of technology for life sciences companies, has launched a new generative AI-powered information platform that enables

Medtech leader Medcura Inc. has added two new leadership team members with extensive experience in science, product development and compliance.

SYNAPS Dx recently participated at BRAINWeek 2023 with the release of compelling data on the performance of the Morphometric Imaging assay of the DISCERN test and the results of a clinical utility study demonstrating the role of DISCERN in informed physician decision-making.

GoodCap Pharmaceuticals Inc. (“GoodCap” or the “Company”), a leading biopharmaceutical company focused on discovering and developing novel anti-inflammatory treatments for mood-disorders

Aegis Sciences Corporation, a health care testing lab based in Nashville, TN, is pleased to announce another expansion of novel psychoactive substance testing for its clients.

Moderna Biopharma Canada Corp. today announced Health Canada has authorized its updated COVID-19 vaccine, SPIKEVAX® XBB.1.5, to prevent COVID-19 in individuals 6 months of age and older.

Codexis, Inc., a leading enzyme engineering company, announced the Company will attend the Cantor Global Healthcare Conference, being held September 26-28, 2023, in New York, New York.

Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced that management will participate at the 2023 Cantor Global Healthcare Conference, taking place September 26-28, 2023, in New York, NY.

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today announced that it will report financial results for the first quarter of fiscal year 2024 before the market open on Wednesday, October 4, 2023.